Cargando…
Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The IMMINENT Study
PRIMARY STUDY OBJECTIVE: To evaluate the economic utility of a fecal biomarker panel structured to suggest alternative, treatable diagnoses in patients with symptoms of irritable bowel syndrome (IBS) by quantifying, comparing, and contrasting health service costs between tested and non-tested patien...
Autores principales: | Parsons, Kelly, Goepp, Julius, Dechairo, Bryan, Fowler, Elizabeth, Markward, Nathan, Hanaway, Patrick, McBride, Teresa, Landis, Darryl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Global Advances in Health and Medicine
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030615/ https://www.ncbi.nlm.nih.gov/pubmed/24891991 http://dx.doi.org/10.7453/gahmj.2013.100 |
Ejemplares similares
-
Frequency of Abnormal Fecal Biomarkers in Irritable Bowel Syndrome
por: Goepp, Julius, et al.
Publicado: (2014) -
Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome
por: Emmanuel, Anton, et al.
Publicado: (2016) -
Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015) -
LHC: démarrage imminent
Publicado: (2008) -
Combinatorial Versus Individual Gene Pharmacogenomic Testing in Mental Health: A Perspective on Context and Implications on Clinical Utility
por: Winner, Joel G., et al.
Publicado: (2015)